Methods of treating hepatic encephalopathy
DC CAFCFirst Claim
Patent Images
1. A method of decreasing a subject'"'"'s risk of a hepatic encephalopathy (HE) breakthrough episode comprising administering rifaximin daily for a period of about 12 months or longer to a subject suffering from HE, thereby decreasing the subject'"'"'s risk of an HE breakthrough episode, wherein a breakthrough episode is defined as an increase of the Conn score to Grade ≧
- 2 or an increase in Conn score of 1 and asterixis grade of 1 for subjects having a baseline Conn score of 0.
13 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin.
33 Citations
29 Claims
-
1. A method of decreasing a subject'"'"'s risk of a hepatic encephalopathy (HE) breakthrough episode comprising administering rifaximin daily for a period of about 12 months or longer to a subject suffering from HE, thereby decreasing the subject'"'"'s risk of an HE breakthrough episode, wherein a breakthrough episode is defined as an increase of the Conn score to Grade ≧
- 2 or an increase in Conn score of 1 and asterixis grade of 1 for subjects having a baseline Conn score of 0.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)
Specification